|
US3796700A
(en)
|
1970-06-30 |
1974-03-12 |
Takedo Chem Ind Ltd |
Adenosine derivatives and the production thereof
|
|
DE2034785A1
(de)
|
1970-07-14 |
1972-01-20 |
Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof |
Adenosin 5 carbonsäurederivate
|
|
CA1019727A
(en)
|
1971-03-18 |
1977-10-25 |
Abbott Laboratories |
Adenosine-5'-carboxylic acid amides
|
|
BE789773A
(fr)
|
1971-10-08 |
1973-04-06 |
Schering Ag |
Adenosines n6 -substituees et leur procede de
|
|
US3864483A
(en)
|
1972-03-22 |
1975-02-04 |
Abbott Lab |
Adenosine-5{40 -carboxylic acid amides
|
|
CA1082695A
(en)
|
1972-04-10 |
1980-07-29 |
Francis E. Fischer |
Process for preparing adenosine-5'-carboxamides
|
|
US3966917A
(en)
|
1974-07-30 |
1976-06-29 |
Abbott Laboratories |
Platelet aggregation inhibitors
|
|
DE2621470A1
(de)
|
1976-05-14 |
1977-12-01 |
Pharma Waldhof Gmbh & Co |
Nucleosidcarbonsaeurenitrile und ihre derivate, und verfahren zu ihrer herstellung
|
|
US4167565A
(en)
|
1976-11-08 |
1979-09-11 |
Abbott Laboratories |
Adenosine-5'-carboxamides and method of use
|
|
AU8379182A
(en)
|
1981-06-04 |
1982-12-09 |
Procter & Gamble Company, The |
Composition of salicylates and purine derivatives
|
|
CA1239397A
(en)
|
1983-08-01 |
1988-07-19 |
James A. Bristol |
N.sup.6-substituted adenosines
|
|
DE3406533A1
(de)
|
1984-02-23 |
1985-08-29 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
|
|
EP0300144A3
(en)
|
1984-04-18 |
1989-09-27 |
Whitby Research Incorporated |
N-6 alkyl substituted adenosine derivatives as cardiac vasodilators
|
|
US5310731A
(en)
|
1984-06-28 |
1994-05-10 |
Whitby Research, Inc. |
N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
|
|
US4663313A
(en)
|
1984-10-26 |
1987-05-05 |
Warner-Lambert Company |
N6 -tricyclic adenosines for treating hypertension
|
|
CA1254888A
(en)
|
1984-10-26 |
1989-05-30 |
Bharat Trivedi |
N.sup.6-bicycloadenosines
|
|
AU575438B2
(en)
|
1984-10-26 |
1988-07-28 |
Warner-Lambert Company |
N6 - substituted deoxyribose analogues of adenosines
|
|
US4738954A
(en)
|
1985-11-06 |
1988-04-19 |
Warner-Lambert Company |
Novel N6 -substituted-5'-oxidized adenosine analogs
|
|
US4755594A
(en)
|
1986-01-31 |
1988-07-05 |
Warner-Lambert Company |
N6 -substituted adenosines
|
|
US5106837A
(en)
|
1988-03-16 |
1992-04-21 |
The Scripps Research Institute |
Adenosine derivatives with therapeutic activity
|
|
JPH0696534B2
(ja)
|
1986-04-25 |
1994-11-30 |
ヘキストジヤパン株式会社 |
抗痴呆剤
|
|
US4767747A
(en)
|
1986-08-28 |
1988-08-30 |
Warner-Lambert Company |
Method for treating congestive heart failure with N6 -acenaphthyl adenosine
|
|
WO1988003148A2
(en)
|
1986-10-31 |
1988-05-05 |
Warner-Lambert Company |
Heteroaromatic derivatives of adenoside
|
|
WO1988003147A1
(en)
|
1986-10-31 |
1988-05-05 |
Warner-Lambert Company |
Selected n6-substituted adenosines having selective a2 binding activity
|
|
HU198950B
(en)
|
1986-12-15 |
1989-12-28 |
Sandoz Ag |
Process for producing new furanuronic acid derivatives and pharmaceutical compositions comprising such compounds
|
|
US4968697A
(en)
|
1987-02-04 |
1990-11-06 |
Ciba-Geigy Corporation |
2-substituted adenosine 5'-carboxamides as antihypertensive agents
|
|
EP0277917A3
(en)
|
1987-02-04 |
1990-03-28 |
Ciba-Geigy Ag |
Certain adenosine 5'-carboxamide derivatives
|
|
US4962194A
(en)
|
1987-04-02 |
1990-10-09 |
Warner-Lambert Company |
Method of preparing 51,N6-disubstituted adenosines from inosines
|
|
LU87181A1
(fr)
|
1987-04-06 |
1988-11-17 |
Sandoz Sa |
Nouveaux derives de l'acide furannuronique,leur preparation et leur utilisation comme medicaments
|
|
US5219840A
(en)
|
1987-04-06 |
1993-06-15 |
Sandoz Ltd. |
Antihypertensive 9-(2,N6 -disubstituted adenyl) ribofuranuronic acid derivatives
|
|
JPH0725785B2
(ja)
|
1989-01-11 |
1995-03-22 |
日本臓器製薬株式会社 |
アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
|
|
US5646128A
(en)
|
1989-09-15 |
1997-07-08 |
Gensia, Inc. |
Methods for treating adenosine kinase related conditions
|
|
US5055569A
(en)
|
1989-10-19 |
1991-10-08 |
G. D. Searle & Co. |
N-(6)-substituted adenosine compounds
|
|
IE903747A1
(en)
|
1989-10-19 |
1991-04-24 |
Searle & Co |
Method of treating gastrointestinal motility disorders
|
|
KR927003044A
(ko)
|
1990-01-11 |
1992-12-17 |
크리스토퍼 케이. 미라벨리 |
Rna 활성과 유전자 발현을 검출하고 조절하는 조성물 및 그 방법
|
|
US5140015A
(en)
|
1990-02-20 |
1992-08-18 |
Whitby Research, Inc. |
2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
|
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
|
US5280015A
(en)
|
1990-09-05 |
1994-01-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
2-substituted adenosines and 2-substituted adenosine 5'-carboxamides
|
|
AU654507B2
(en)
|
1990-09-25 |
1994-11-10 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Compounds having antihypertensive and anti-ischemic properties
|
|
CA2100863A1
(en)
|
1991-01-23 |
1992-07-24 |
David A. Bullough |
Adenosine kinase inhibitors
|
|
GB9127376D0
(en)
|
1991-12-24 |
1992-02-19 |
Wellcome Found |
Amidino derivatives
|
|
FR2685918B1
(fr)
|
1992-01-08 |
1995-06-23 |
Union Pharma Scient Appl |
Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
|
|
FR2687678B1
(fr)
|
1992-01-31 |
1995-03-31 |
Union Pharma Scient Appl |
Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
|
|
US5552438A
(en)
|
1992-04-02 |
1996-09-03 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
|
US5424297A
(en)
|
1992-04-27 |
1995-06-13 |
University Of Virginia Alumni Patents Foundation |
Adenosine dextran conjugates
|
|
WO1994002497A1
(en)
|
1992-07-15 |
1994-02-03 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Sulfo-derivatives of adenosine
|
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
|
WO1994018215A1
(en)
|
1993-02-03 |
1994-08-18 |
Gensia, Inc. |
Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
|
|
IL108523A0
(en)
|
1993-02-03 |
1994-05-30 |
Gensia Inc |
Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
|
|
WO1995002604A1
(en)
|
1993-07-13 |
1995-01-26 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
A3 adenosine receptor agonists
|
|
US5446046A
(en)
|
1993-10-28 |
1995-08-29 |
University Of Florida Research Foundation |
A1 adenosine receptor agonists and antagonists as diuretics
|
|
WO1995018817A1
(fr)
|
1994-01-07 |
1995-07-13 |
Laboratoires Upsa |
Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
|
|
DE69529101T2
(de)
|
1994-06-15 |
2003-11-13 |
Wellcome Found |
Zwischenprodukte verwendbar in der Herstellung von Enzym-Inhibitoren
|
|
GB9414208D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
|
GB9414193D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
|
JPH11505702A
(ja)
*
|
1995-05-18 |
1999-05-25 |
コールター インターナショナル コーポレイション |
アッセイ試薬及び前記アッセイ試薬の製造及び使用方法
|
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
|
US5789589A
(en)
|
1996-04-22 |
1998-08-04 |
Drug Innovation & Design, Inc. |
Guanine analog phosphates
|
|
WO1998001459A1
(en)
|
1996-07-05 |
1998-01-15 |
Novo Nordisk A/S |
Novel n-alkoxyadenine derivatives acting as cytokine inhibitors
|
|
UA51716C2
(uk)
|
1996-07-08 |
2002-12-16 |
Авентіс Фармасьютікалз Продактс Інк. |
Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування
|
|
AU4377397A
(en)
|
1996-10-14 |
1998-05-11 |
Novo Nordisk A/S |
Novel therapeutically active adenosine derivatives
|
|
TW528755B
(en)
|
1996-12-24 |
2003-04-21 |
Glaxo Group Ltd |
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
|
|
US6710051B1
(en)
|
1997-01-06 |
2004-03-23 |
Klaus Trier Aps |
Screening method
|
|
MY117948A
(en)
|
1997-01-13 |
2004-08-30 |
Glaxo Group Ltd |
Nitride oxide synthase inhibitors.
|
|
DE19723722A1
(de)
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
|
WO1999016766A1
(en)
|
1997-10-01 |
1999-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Benzodioxole derivatives
|
|
YU44900A
(sh)
|
1998-01-31 |
2003-01-31 |
Glaxo Group Limited |
Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
|
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
|
AR017457A1
(es)
|
1998-02-14 |
2001-09-05 |
Glaxo Group Ltd |
Compuestos derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol, procesos para su preparacion, composiciones que los contienen y su uso en terapia para el tratamiento de enfermedades inflamatorias.
|
|
SI1070056T1
(en)
|
1998-03-14 |
2004-12-31 |
Altana Pharma Ag |
Phthalazinone pde iii/iv inhibitors
|
|
GB9811599D0
(en)
|
1998-05-30 |
1998-07-29 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
|
JP3933870B2
(ja)
|
1998-06-23 |
2007-06-20 |
グラクソ グループ リミテッド |
２−（プリン−９−イル）−テトラヒドロフラン−３，４−ジオール誘導体
|
|
GB9813565D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB9813540D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
|
MY121142A
(en)
|
1999-02-23 |
2005-12-30 |
Smithkline Beecham Corp |
Controlled release formulation for treating copd
|
|
WO2000066590A2
(en)
|
1999-05-04 |
2000-11-09 |
Ligand Pharmaceuticals, Inc. |
Tetracyclic progesterone receptor modulator compounds and methods
|
|
US6841549B1
(en)
|
1999-07-02 |
2005-01-11 |
Eisai Co., Ltd. |
Condensed imidazole compounds and a therapeutic agent for diabetes mellitus
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
US6263209B1
(en)
|
1999-07-28 |
2001-07-17 |
Motorola, Inc. |
Method and apparatus in a wireless communication system for creating a learning function
|
|
CO5180649A1
(es)
|
1999-09-01 |
2002-07-30 |
Abbott Lab |
Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
|
|
US6803457B1
(en)
|
1999-09-30 |
2004-10-12 |
Pfizer, Inc. |
Compounds for the treatment of ischemia
|
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
|
CZ20022413A3
(cs)
|
2000-01-31 |
2003-08-13 |
Pfizer Products Inc. |
Pyrimidinkarboxamidy užitečné jako inhibitory isozymů PDE4
|
|
CZ20022410A3
(cs)
|
2000-01-31 |
2003-08-13 |
Pfizer Products Inc. |
Benzoanelované heterocyklylové deriváty nikotinamidu užitečné jako selektivní inhibitory isozymů PDE4
|
|
US7585847B2
(en)
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
US6710086B1
(en)
|
2000-02-25 |
2004-03-23 |
Medinox, Inc. |
Protected forms of pharmacologically active agents and uses therefor
|
|
US6753322B2
(en)
|
2000-06-06 |
2004-06-22 |
Pfizer Inc |
2-aminocarbonyl-9H-purine derivatives
|
|
US6921753B2
(en)
|
2000-06-27 |
2005-07-26 |
Pfizer Inc |
Purine derivatives
|
|
GB0015727D0
(en)
|
2000-06-27 |
2000-08-16 |
Pfizer Ltd |
Purine derivatives
|
|
GB0016002D0
(en)
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
EP1324990B1
(en)
|
2000-09-29 |
2014-10-29 |
Glaxo Group Limited |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
|
|
AU2002210761A1
(en)
|
2000-11-03 |
2002-05-15 |
Glaxo Group Limited |
Method of determining susceptibility to diseases
|
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
|
GB0031179D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
|
DE10064997A1
(de)
|
2000-12-23 |
2002-06-27 |
Merck Patent Gmbh |
Benzoylpyridazine
|
|
US6484903B2
(en)
|
2001-01-09 |
2002-11-26 |
Riverwood International Corporation |
Carton with an improved dispensing feature in combination with a unique handle
|
|
US7589075B2
(en)
|
2001-01-16 |
2009-09-15 |
Can-Fite Biopharma Ltd. |
Use of an adenosine A3 receptor agonist for inhibition of viral replication
|
|
DE60203652T2
(de)
|
2001-01-31 |
2005-09-08 |
Pfizer Products Inc., Groton |
Nikotinsäureamid-Derivate und ihre Mimetika als Inhibitoren von PDE4-Isozyme
|
|
US7250518B2
(en)
|
2001-01-31 |
2007-07-31 |
Pfizer Inc. |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0104555D0
(en)
|
2001-02-23 |
2001-04-11 |
Glaxo Group Ltd |
New Therapeutic method
|
|
GB2372742A
(en)
|
2001-03-03 |
2002-09-04 |
Univ Leiden |
C2,5'-Disubstituted and N6,C2,5'-trisubstituted adenosine derivatives and their different uses
|
|
US7144908B2
(en)
|
2001-03-08 |
2006-12-05 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
|
WO2002072067A2
(en)
|
2001-03-12 |
2002-09-19 |
Glaxo Group Limited |
Pharmaceutical aerosol formulation
|
|
ES2296923T3
(es)
|
2001-03-22 |
2008-05-01 |
Glaxo Group Limited |
Derivados formanilidas como agonistas del adrenorreceptor beta2.
|
|
EP1491541B1
(en)
|
2001-03-30 |
2007-01-24 |
Pfizer Products Inc. |
Pyridazinone aldose reductase inhibitors
|
|
US20040204481A1
(en)
|
2001-04-12 |
2004-10-14 |
Pnina Fishman |
Activation of natural killer cells by adenosine A3 receptor agonists
|
|
US6903109B2
(en)
|
2001-04-18 |
2005-06-07 |
Ortho-Muniel Pharmaceutical, Inc. |
Arylindenopyridines and related therapeutic and prophylactic methods
|
|
GB0120124D0
(en)
|
2001-05-04 |
2001-10-10 |
Aventis Pharm Prod Inc |
Effect of timing and duration of administration of amp 579 on reperfusion injury in rabbit heart
|
|
WO2002096462A1
(en)
|
2001-05-25 |
2002-12-05 |
Pfizer Inc. |
An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases
|
|
US20030013675A1
(en)
|
2001-05-25 |
2003-01-16 |
Boehringer Ingelheim Pharma Kg |
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
|
|
US7262176B2
(en)
|
2001-08-08 |
2007-08-28 |
Cv Therapeutics, Inc. |
Adenosine A3 receptor agonists
|
|
US20030078232A1
(en)
|
2001-08-08 |
2003-04-24 |
Elfatih Elzein |
Adenosine receptor A3 agonists
|
|
KR20090057477A
(ko)
|
2001-09-14 |
2009-06-05 |
글락소 그룹 리미티드 |
호흡기 질환 치료용 펜에탄올아민 유도체
|
|
NZ556354A
(en)
|
2001-10-01 |
2008-10-31 |
Univ Virginia |
2-Propynyl adenosine analogs having A2A agonist activity and compositions thereof
|
|
US20040259863A1
(en)
|
2001-10-31 |
2004-12-23 |
Hans-Michael Eggenweiler |
Type 4 phosphodiesterase inhibitors and uses thereof
|
|
PL369074A1
(en)
|
2001-11-02 |
2005-04-18 |
Aventis Pharmaceuticals Inc. |
Pharmaceutical composition comprising an adenosine a1/a2 agonist and a sodium hydrogen exchanger inhibitor
|
|
PL369738A1
(en)
|
2001-11-05 |
2005-05-02 |
Merck Patent Gmbh |
Hydrazono-malonitriles
|
|
US6653323B2
(en)
|
2001-11-13 |
2003-11-25 |
Theravance, Inc. |
Aryl aniline β2 adrenergic receptor agonists
|
|
US6911453B2
(en)
|
2001-12-05 |
2005-06-28 |
Aventis Pharma Deutschland Gmbh |
Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
|
|
GB0129273D0
(en)
|
2001-12-06 |
2002-01-23 |
Pfizer Ltd |
Crystalline drug form
|
|
US6703405B2
(en)
|
2001-12-22 |
2004-03-09 |
Aventis Pharma Deutschland Gmbh |
Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them
|
|
DE10163991A1
(de)
|
2001-12-24 |
2003-07-03 |
Merck Patent Gmbh |
Pyrrolo-pyrimidine
|
|
AU2003202216A1
(en)
|
2002-01-14 |
2003-07-30 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
|
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
|
CA2473886C
(en)
|
2002-01-22 |
2012-08-21 |
The Regents Of The University Of California |
Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
|
|
CA2474337A1
(en)
|
2002-01-25 |
2003-07-31 |
Muscagen Limited |
Compounds useful as a3 adenosine receptor agonists
|
|
MXPA04007737A
(es)
|
2002-02-11 |
2004-10-15 |
Pfizer |
Derivados de nicotinamida utiles como inhibidores de fosfodesterasas 4.
|
|
US6756392B2
(en)
|
2002-02-11 |
2004-06-29 |
Pfizer Inc |
Nicotinamide derivatives useful as PDE4 inhibitors
|
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
|
AU2003213402A1
(en)
|
2002-03-18 |
2003-09-29 |
Yamanouchi Pharmaceutical Co., Ltd. |
Powdery medicinal compositions for inhalation and process for producing the same
|
|
WO2003080053A1
(en)
|
2002-03-18 |
2003-10-02 |
Schering Corporation |
Combination treatments for chemokine-mediated diseases
|
|
GB0206657D0
(en)
|
2002-03-21 |
2002-05-01 |
Glaxo Group Ltd |
Novel intermediate and process
|
|
GB0206655D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Glaxo Group Ltd |
Novel process
|
|
WO2003082787A1
(en)
|
2002-03-26 |
2003-10-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
CA2478156C
(en)
|
2002-03-26 |
2011-02-15 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
DE10215316C1
(de)
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
|
EP1496892B1
(en)
|
2002-04-11 |
2011-01-26 |
Merck Sharp & Dohme Corp. |
1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators
|
|
GB0208608D0
(en)
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
|
US20040127510A1
(en)
|
2002-04-16 |
2004-07-01 |
Heintzelman Geoffrey R. |
Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
|
|
JP2005523920A
(ja)
|
2002-04-25 |
2005-08-11 |
グラクソ グループ リミテッド |
フェネタノールアミン誘導体
|
|
AU2003251303A1
(en)
|
2002-05-21 |
2003-12-12 |
Glaxo Group Limited |
Pharmaceutical products and methods of manufacture
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
JP4503436B2
(ja)
|
2002-07-08 |
2010-07-14 |
ファイザー・プロダクツ・インク |
糖質コルチコイド受容体のモジュレーター
|
|
DE60331103D1
(de)
|
2002-07-18 |
2010-03-11 |
Bristol Myers Squibb Co |
Zusammensetzungen und verfahren im zusammenhang mit der nuklearen hormon-rezeptor-stelle ii
|
|
EP1534273A4
(en)
|
2002-07-18 |
2007-08-22 |
Bristol Myers Squibb Co |
MODULATORS OF THE GLUCOCORTICOID RECEPTOR AND METHOD
|
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
JP2006504678A
(ja)
|
2002-08-21 |
2006-02-09 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
|
|
WO2004084800A2
(en)
|
2002-08-29 |
2004-10-07 |
Pfizer Products Inc. |
A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
|
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
|
BR0314450A
(pt)
|
2002-09-09 |
2005-07-26 |
Trigen Ltd |
Sais de ácido borÈnico com adição de uma base farmaceuticamente aceitável, formulação farmacêutica, e uso dos referidos sais para preparar uma formulação farmacêutica
|
|
US6914053B2
(en)
|
2002-09-09 |
2005-07-05 |
Cv Therapeutics, Inc. |
Adenosine A3 receptor agonists
|
|
US20050288253A1
(en)
|
2002-09-09 |
2005-12-29 |
Trigen Limited |
Boronic acid salts
|
|
EP2298338B1
(en)
|
2002-09-16 |
2012-08-22 |
Agennix Incorporated |
Lactoferrin compositions and methods of treatment of skin wounds
|
|
JP2006503108A
(ja)
|
2002-09-16 |
2006-01-26 |
グラクソ グループ リミテッド |
ピラゾロ［３，４−ｂ］ピリジン化合物およびそれのホスホジエステラーゼ阻害薬としての使用
|
|
AU2003270783C1
(en)
|
2002-09-20 |
2010-05-20 |
Merck Sharp & Dohme Corp. |
Octahydro-2-H-naphtho[1,2-F] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
|
US20040229780A1
(en)
|
2002-09-20 |
2004-11-18 |
Olivera Baldomero M. |
KappaM-conopeptides as organ protectants
|
|
WO2004028338A2
(en)
|
2002-09-27 |
2004-04-08 |
King Pharmaceuticals Research And Development, Inc. |
A method to demonstrate the efficacy of pharmacological stress agent
|
|
WO2004030621A2
(en)
|
2002-09-30 |
2004-04-15 |
The Trustees Of Boston University |
Method of treating cancer using adenosine and its analogs
|
|
PE20040570A1
(es)
|
2002-10-09 |
2004-08-30 |
Pharmacopeia Drug Discovery |
Tiadiazoldioxidos y tiadiazoloxidos como ligandos del receptor de cxc- y cc-quimiocina
|
|
ES2302938T3
(es)
|
2002-10-11 |
2008-08-01 |
Pfizer Inc. |
Derivados de indol como agonistas beta-2.
|
|
EP1407769A1
(en)
|
2002-10-11 |
2004-04-14 |
Pfizer Limited |
Indole derivatives as beta-2 agonists
|
|
US6844362B2
(en)
|
2002-10-11 |
2005-01-18 |
Pfizer Inc |
Indole derivatives useful for the treatment of diseases
|
|
EP1554264B1
(en)
|
2002-10-22 |
2007-08-08 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
|
AU2003301589A1
(en)
|
2002-10-25 |
2004-05-13 |
Ewha Womans University |
Purine nucleosides
|
|
EP1556342B1
(en)
|
2002-10-28 |
2008-03-26 |
Glaxo Group Limited |
Phenethanolamine derivative for the treatment of respiratory diseases
|
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
|
US7745431B2
(en)
|
2002-12-03 |
2010-06-29 |
Vela Acquisition Corporation |
Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereof
|
|
GB0228723D0
(en)
|
2002-12-09 |
2003-01-15 |
Cambridge Biotechnology Ltd |
Treatment of pain
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
EP1587512A2
(en)
|
2003-01-14 |
2005-10-26 |
ALTANA Pharma AG |
Pde4 inhibitors for the treatment of neoplasms of lymphoid cells
|
|
US20040166574A1
(en)
|
2003-02-25 |
2004-08-26 |
Antonius John I. |
Microorganism
|
|
US20040175382A1
(en)
|
2003-03-06 |
2004-09-09 |
Schafer Peter H. |
Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
|
|
GB0305150D0
(en)
|
2003-03-07 |
2003-04-09 |
Cambridge Biotechnology Ltd |
Use of therapeutic compounds
|
|
GB0305153D0
(en)
|
2003-03-07 |
2003-04-09 |
Cambridge Biotechnology Ltd |
Identification of therapeutic compounds
|
|
GB0305149D0
(en)
|
2003-03-07 |
2003-04-09 |
Cambridge Biotechnology Ltd |
Compounds for the treatment of pain
|
|
EP1460064A1
(en)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Indole-2-carboxamide derivatives useful as beta-2 agonists
|
|
US20040184995A1
(en)
|
2003-03-17 |
2004-09-23 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel dry powder inhalation for lung-delivery and manufacturing method thereof
|
|
US20040258740A1
(en)
|
2003-04-10 |
2004-12-23 |
Nene Labs |
Transdermal delivery composition
|
|
CA2522666A1
(en)
|
2003-04-18 |
2004-10-28 |
Pharmacia & Upjohn Company Llc |
Combination therapies for chronic obstructive pulmonary disease (copd)
|
|
US7268147B2
(en)
|
2003-05-15 |
2007-09-11 |
Pfizer Inc |
Compounds useful for the treatment of diseases
|
|
EP1477167A1
(en)
|
2003-05-15 |
2004-11-17 |
Pfizer Limited |
[(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists
|
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
EP1633714B1
(en)
|
2003-06-04 |
2008-01-23 |
Pfizer Limited |
2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists
|
|
US7067541B2
(en)
|
2003-06-04 |
2006-06-27 |
Pfizer Inc |
2-amino-pyridine derivatives useful for the treatment of diseases
|
|
US7375100B2
(en)
|
2003-06-04 |
2008-05-20 |
Pfizer Inc |
2-amino-pyridine derivatives useful for the treatment of diseases
|
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
|
WO2004110454A1
(ja)
|
2003-06-13 |
2004-12-23 |
Ishihara Sangyo Kaisha, Ltd. |
アデノシンＡ2ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
|
|
US6974862B2
(en)
|
2003-06-20 |
2005-12-13 |
Kensey Nash Corporation |
High density fibrous polymers suitable for implant
|
|
GB0317484D0
(en)
|
2003-07-25 |
2003-08-27 |
Pfizer Ltd |
Nicotinamide derivatives useful as pde4 inhibitors
|
|
GB0317498D0
(en)
|
2003-07-25 |
2003-08-27 |
Pfizer Ltd |
Compounds
|
|
GB0317482D0
(en)
|
2003-07-25 |
2003-08-27 |
Pfizer Ltd |
Nicotinamide derivatives useful as pde4 inhibitors
|
|
GB0317471D0
(en)
|
2003-07-25 |
2003-08-27 |
Pfizer Ltd |
Novel compounds
|
|
US7153870B2
(en)
|
2003-07-25 |
2006-12-26 |
Pfizer Inc. |
Nicotinamide derivatives useful as PDE4 inhibitors
|
|
US20050020587A1
(en)
|
2003-07-25 |
2005-01-27 |
Pfizer Inc |
Nicotinamide derivatives useful as PDE4 inhibitors
|
|
GB0317509D0
(en)
|
2003-07-25 |
2003-08-27 |
Pfizer Ltd |
Nicotinamide derivatives useful as PDE4 inhibitors
|
|
US7132435B2
(en)
|
2003-07-25 |
2006-11-07 |
Pfizer Inc. |
Compounds
|
|
GB0317516D0
(en)
|
2003-07-25 |
2003-08-27 |
Pfizer Ltd |
Nicotinamide derivatives useful as PDE4 inhibitors
|
|
GB0317472D0
(en)
|
2003-07-25 |
2003-08-27 |
Pfizer Ltd |
Nicotinamide derivatives useful as PDE4 inhibitors
|
|
GB0317951D0
(en)
|
2003-07-31 |
2003-09-03 |
Trigen Ltd |
Compounds
|
|
NZ545979A
(en)
|
2003-09-18 |
2009-02-28 |
King Pharmaceuticals Res & Dev |
Novel adenosine A3 receptor agonists
|